This study plans to learn more about how children use their asthma medicines. The investigators would like to see if special electronic monitoring devices that connect to smartphones and computers can help children to better manage their asthma

Inclusion Criteria:

• age 6-17 years and their parents
• either 2 emergency department visits/prednisone bursts in the last 12 months or at least 1 asthma related hospitalization in the last 12 months
• requiring daily controller therapy with either inhaled corticosteroids or combination corticosteroids/long acting beta agonist (LABA).
• Patients using metered dose inhaler therapy would be eligible. Patients may also be on leukotriene antagonists,
• Must be made aware that they will have to read and accept to the terms of the User Agreement prior to enrollment in the study. If they do not agree they will not be able to continue participation. The User agreement will be read agreed to electronically when they begin using the device, however a paper version will be provided at the time of consent upon request.

Exclusion Criteria:

• Primary language other than English or Spanish
• Presence of other significant chronic lung disease including cystic fibrosis, interstitial lung disease, tracheostomy status.
• Patients using diskus therapy.
• Patients only on leukotriene antagonists.

Study subjects would be drawn from the list of high risk asthma patients and by pre-clinic chart review done by study investigator.